Background In the North West of England, data on drug users are routinely collected from a variety of agencies including specialist treatment centres, police and probation services. However, the covert nature of drug use means that alone, these conventional monitoring systems cannot provide the epidemiology required to target and develop drug treatment and prevention initiatives.
Introduction
The covert nature of illicit drug use creates particular problems for the planning and assessment of both drug treatment services and prevention initiatives. For instance, objectives of the British anti-drugs strategy 1 include diverting more drug users away from judicial systems into treatment-based alternatives and reducing the proportion of people under 25 reporting use of illegal drugs. 1 However, successfully meeting either objective requires epidemiological information on drug use beyond that currently available through conventional monitoring systems. 2 Consequently, initiatives to move individuals from judicial to treatment pathways [e.g. Arrest Referral (AR) 3 and Drug Treatment and Testing Orders (DTTO) 4 ] have begun but without suitable information on the changes in treatment capacity necessary to meet these new challenges. Equally, monitoring the actual proportion of young people (under 25) with drug problems requires measuring not only the number of young people in contact with services but also the unknown number using drugs throughout the community that potentially require treatment.
Capture-recapture (CR) analysis allows an estimation of the number of individuals within a given population in situations where it is often impossible to conduct a straightforward count. This approach was originally applied to animal studies 5 but more recently it has been used to estimate the size of human populations with conditions such as diabetes, 6 whooping cough, 7 tuberculosis 8 and drug misuse. [9] [10] [11] For human populations, the Hidden need for drug treatment services: measuring levels of problematic drug use in the North West of England technique utilizes multiple databases all potentially capable of capturing (i.e. recording) the same individuals with the particular condition in question. The pattern of overlap between databases can, using log-linear modelling, 12 be used to estimate the additional number of individuals with a particular characteristic but who do not appear on any of the databases. Capturerecapture is well suited to estimating drug-using populations as factors such as illegality and stigmatization of drugs often demand covert use. However, previous studies have often relied on isolated data surveys and therefore consistent and repeated estimates have not been possible.
Here we use a variety of enhanced drug monitoring databases developed in the North West of England and data from existing surveys of problematic drug users to estimate the total number of problematic drug users, their age and sex characteristics in five health authorities (HA) and one local authority (LA). Furthermore, we estimate the proportion of problematic drug users already in treatment and the required growth in service capacity necessary to deliver treatment to all problematic users.
Methods
For each CR analysis a minimum of three independent data sources were required covering each geographical area. 13 Overlap (i.e. the same individual appearing on more than one database) could be calculated, as all data systems record initials, dates of birth, sex and some geographical information (usually health authority of residence or treatment). In all areas except Manchester the three sources of data used in the model were drug treatment agencies, police and probation. For Manchester, accident and emergency data replaced probation. Manchester HA and Bolton LA data cover the calendar year 1997, Liverpool HA 1998 and Sefton, St. Helens & Knowsley and Wirral HAs 1999. Choice of year was dictated by the most recent sets of data available and suitable for CR analysis.
Data from drug treatment agencies included those from statutory and voluntary drug agencies such as Drug Dependency Clinics, Community Drugs Teams and Residential Rehabilitation Centres. 2, 14, 15 For Merseyside health authorities (Liverpool, Sefton, St Helens & Knowsley and Wirral) these data were provided by the outcomes and prevalence database. 15, 16 This database annually records all drug users in contact with drug treatment services. For Manchester HA and Bolton LA treatment data were provided by the Regional Drug Misuse Database (DMD). 17 As part of a national monitoring system, the DMD records data on individuals presenting at services with new requests for treatment.
For Merseyside health authorities, police datasets included only those individuals arrested for a drug crime; usually possession, possession with the intent to supply and supply. These data were taken from the Inter-Agency Drug Misuse Database (IAD); a multi-agency drug database recording drug users contacting health or judicial systems. 14, 18 Bolton and Manchester police data were from police surgeons and included those arrested specifically for drug crimes as well as individuals arrested for other crimes but subsequently identified as having a drug problem. For Manchester and Bolton, these data were extracted from the DMD.
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Probation data comprise individuals in contact with the Probation Service who have disclosed a drug problem to that service. In Merseyside data were extracted from the IAD; 14, 18 in Manchester and Bolton they were provided through an independent research survey undertaken in 1997. 19 Accident and Emergency figures included data recorded on any admission where the clinician considered drug misuse to be a factor. These data are from an unpublished Accident and Emergency research study at Manchester Royal Infirmary Emergency Department and cover only the Manchester area.
In all cases individuals were considered to be problematic drug users only if they were reported by any Specialist Drug Service or were reported from any of the other data sources as users of heroin, methadone, cocaine or crack cocaine. Individuals reported for using only cannabis, ecstasy or amphetamine were not included. The majority (92.3 per cent) of individuals identified as problematic drug users were aged between 15 and 44. For the purposes of more robust analysis, and later to allow age-specific rates to be calculated, any individuals aged below 15 or aged 45 and over were also removed. Numbers included in the final data analyses are given in Table 1 categorized by age, sex, reporting agency type and geographical area of report.
For CR, data were placed in a 2 n contingency table (where n is number of sources) for Poisson log-linear modelling. Best fit between model and observed data is calculated by comparing observed overlaps between datasets with those generated by the model. Such comparisons utilize a 2 test (excluding the value generated by the model for individuals not observed in any datasets; i.e. the unobserved cell). We fit the model with the fewest possible parameters that is not significantly different (p Ͼ 0.05) from observed values. Finally, we use the model to predict the value of the unobserved cell. Full mathematical details of estimating the size of a closed population have been published in detail elsewhere. 13 All analyses were undertaken using SPSS 20 and Generalized Linear Interactive Modelling (GLIM) 21 statistical software.
Results
Capture-recapture estimates [Ϯ95 per cent confidence intervals (CIs)] for all problematic drug users are presented in Table 2 .
Measures of closeness of fit between observed data and that generated by the models and any interaction parameters 13 between datasets are also given. Nearly all (27 of 30) models fitted observed data well (i.e. did not differ significantly), increasing confidence in the estimates of the hidden population. For those that differed statistically (Liverpool's overall and 25-44 years and Sefton's female estimates) the difference only just reached significance (p ϭ 0.048, 0.037 and 0.032, respectively). To correct for differences in sizes and population structures across different geographical areas, rates of problem drug use per 1000 population were calculated (see Table 3 ). For all drug users (aged 15-44) rates per 1000 ranged from 17. 8 
Discussion
Developing appropriate drug services, targeting prevention strategies as well as monitoring effectiveness all require information on drug users not just in contact with services, but throughout the wider community. Capture-recapture (CR) offers one method of monitoring this population and provides important perspectives on the demography of hidden drug users, penetration of users into treatment services and consequently, the needs for further service and prevention development. The analyses presented here demonstrate that CR can be implemented as part of routine monitoring.
This approach makes a number of assumptions. First, the population is assumed to be closed (i.e. with no substantial changes in the population under study during the CR period). Although deaths and migration will have occurred during our study periods, surveillance indicates that levels are low 15 and consequently, unlikely to significantly affect estimates. Second, CR assumes data sources are independent of one another. At the time of this study, referral of drug users between judicial and health agencies was not common practice. Furthermore, by using log-linear modelling we have been able to control for dependences between data sources by including appropriate interaction terms in the model (see Table 2 ). Finally, all members of the population should have the same probability of being captured. Stratifying CR analyses by either age or sex did not alter estimates for problematic drug use (Table 2) , suggesting consistent capture (at least by sex and age) between databases. More importantly, however, despite the use of sometimes very different data sources for different areas (compare Manchester and Liverpool), the CR results appear consistent with, for instance, 36.5 and 34.5 problematic drug users per 1000 in Manchester and Liverpool, respectively. Other estimates in the United Kingdom include 3.1 per cent problem drug users (age 15-49) in Lamberth, Southwark and Lewisham HA in 1992 and, for problem opiate users in Newham HA, 3.3 per cent in 1995. 11 A previous study in Liverpool 10 estimated problematic drug use in the 15-29 age band at 16.9 per 1000 in 1991. This compares with a rate of 19.1 per 1000 (ages [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] identified in this study, suggesting (for Liverpool) a rise in levels of problematic drug use.
The size of CR study undertaken here has allowed us to highlight a number of hitherto hidden demographic features of drug use. Thus, large metropolitan areas (here Liverpool and Manchester) appear to conceal disproportionate numbers of problematic drug use (Table 2 ). Furthermore, analyses by age group suggest that higher rates of drug use in metropolitan areas are due primarily to higher number of older users. Thus, although Liverpool has higher rates of drug use in the 25-44 age band than surrounding areas (Sefton, St Helens & Knowsley, Wirral) the difference is not apparent in the younger age band (Table 3) . Comparisons between Manchester and its neighbour (Bolton) show a similar pattern. This may result from much older epidemics of drug use around larger metropolitan areas. Equally, however, migration of established drug users into larger metropolitan areas later in their drug use career could also contribute to this age distribution. Further research would be needed to identify the relative strength of these effects.
Overall, younger drug users were also disproportionately represented in the hidden population (71. 24 Results indicate that only a third of problematic drug users between 25 and 44 years are in contact with specialist drug services and that this falls to less than a quarter in those under 25. Recent evidence suggests that within 2 years of being discharged drug free from services many of those individuals will be back in treatment. 15 Treatment services, often already with lengthy waiting lists, require substantial growth to meet hidden demand from established users, new users and those relapsing. Without such growth, new initiatives (e.g. AR 3 and DTTO 4 ) designed to bring more individuals into treatment cannot function optimally. In the United Kingdom, drug services have been required to increase the number of problematic drug users in treatment by 66 per cent by 2005 and 100 per cent by 2008. 25 Analyses in this study indicate that even an immediate 100 per cent increase in number of users in treatment would (for Merseyside) leave approximately one-third of problematic users outside of service contact. However, the health benefits 26 and economics 27 of continuous growth in treatment services should be weighed against alternatives including more holistic packages for those already in treatment and broader prevention initiatives. A stronger focus on users' physical and social environment 28 (compared with maintenance therapy) may improve success in attaining and maintaining a drug-free status and therefore reduce pressures for service growth. Furthermore, efforts to engage younger age groups in treatment may prove successful in reducing problematic incidence by engaging people in treatment before problematic use is well established.
The new national drug misuse database, due to be launched for England and Wales in 2001, 29 is broadly based on the enhanced surveillance systems developed in Merseyside 15 and used in these analyses. Consequently, from 2002 routine CR analyses using health and judicial data to identify proportions of individuals in treatment could be possible across England. Paradoxically, as referrals from the judicial system (i.e. AR and DTTO) account for more individuals in treatment, independence between data samples will be compromised and CR analysis made more difficult. However, with the inclusion of more partners in drug use surveillance and intelligence (e.g. social services, prisons and accident and emergency units) such anomalies can be more effectively corrected. 13, 14 Thus, greater multiagency collaboration appears to provide the potential both for better monitoring of problematic drug use and for more effective remedies that address both the causes of use and the behavioural and physiological problems associated with addiction.
